CNR Institutional Research Information System

PROSPERI, ENNIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.551
NA - Nord America 1.438
SA - Sud America 511
EU - Europa 417
AF - Africa 48
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.342
SG - Singapore 1.246
CN - Cina 447
BR - Brasile 407
HK - Hong Kong 350
VN - Vietnam 229
FR - Francia 155
KR - Corea 75
CA - Canada 60
IT - Italia 51
GB - Regno Unito 47
DE - Germania 40
IN - India 40
JP - Giappone 36
AR - Argentina 30
BD - Bangladesh 29
EC - Ecuador 23
NL - Olanda 22
BE - Belgio 17
LT - Lituania 17
MX - Messico 17
ZA - Sudafrica 16
ID - Indonesia 15
CO - Colombia 13
UA - Ucraina 13
IL - Israele 11
MA - Marocco 11
TR - Turchia 11
CL - Cile 10
RU - Federazione Russa 10
PY - Paraguay 9
SA - Arabia Saudita 9
VE - Venezuela 9
ES - Italia 8
FI - Finlandia 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
UZ - Uzbekistan 6
EG - Egitto 5
KE - Kenya 5
PK - Pakistan 5
AT - Austria 4
KZ - Kazakistan 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
SE - Svezia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
IE - Irlanda 3
JM - Giamaica 3
RO - Romania 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PL - Polonia 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LC - Santa Lucia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PF - Polinesia Francese 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 4.968
Salva come PNG Salva come JPEG
Città #
Santa Clara 754
Singapore 748
Hong Kong 344
Hefei 172
Lauterbourg 149
Ho Chi Minh City 96
San Jose 94
Seoul 70
Ashburn 63
Beijing 63
Los Angeles 50
Hanoi 40
São Paulo 35
Toronto 30
Frankfurt am Main 25
Tokyo 24
Dallas 23
Brussels 16
Buffalo 16
Da Nang 15
New York 15
Ottawa 13
Rio de Janeiro 12
Guangzhou 11
Amsterdam 10
Johannesburg 10
London 10
Minamishinagawa 10
Quito 10
Atlanta 8
Dhaka 8
Orem 8
Belo Horizonte 7
Bengaluru 7
Curitiba 7
Guayaquil 7
Milan 7
Brasília 6
Campinas 6
Goiânia 6
Ha Long 6
Helsinki 6
Istanbul 6
Jakarta 6
Sassari 6
Bắc Ninh 5
Guarulhos 5
Haiphong 5
Mauá 5
Montreal 5
Porto Alegre 5
Recife 5
Salvador 5
Santo André 5
Tashkent 5
Asunción 4
Biên Hòa 4
Brooklyn 4
Cairo 4
Charlotte 4
Dubai 4
Durban 4
Fortaleza 4
Hải Dương 4
Manchester 4
Mumbai 4
Nairobi 4
New Delhi 4
Ninh Bình 4
Phủ Lý 4
Quận Bảy 4
Ribeirão Preto 4
Riyadh 4
São Bernardo do Campo 4
Thái Nguyên 4
Barbianello 3
Bauru 3
Buenos Aires 3
Chicago 3
Cincinnati 3
Ciudad del Este 3
Düsseldorf 3
Elk Grove Village 3
Fargo 3
Florence 3
Formosa 3
Guro-gu 3
Hangzhou 3
Heilbronn 3
Houston 3
Hòa Bình 3
Kingston 3
Lima 3
Manaus 3
Maracaibo 3
Mariano Moreno 3
Marrakesh 3
Miami 3
Naples 3
Nha Trang 3
Totale 3.240
Salva come PNG Salva come JPEG
Nome #
Assessing Cell Cycle Independent Function of the CDK Inhibitor p21(CDKN¹A) in DNA Repair 85
Proliferating cell nuclear antigen complex formation induced by ultraviolet irradiation in human quiescent fibroblasts as detected by immunostaining and flow cytometry. 68
Histochemical model studies of enzyme activity after thermal damage. 64
Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. 61
p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites. 61
PCNA acetylation by CBP/p300 links its degradation to DNA repair synthesis 58
DNA damage response: multiple roles for p21CDKN1A. 56
Revisiting the Function of p21CDKN1A in DNA Repair: The Influence of Protein Interactions and Stability 55
Single Cell Determination of 7,8-dihydro-8-oxo-2'-deoxyguanosine by Fluorescence Techniques: Antibody vs. Avidin Labeling 51
p21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives 49
Effects of isolation conditions on the cytometric evaluation of chromatin structure in rat myocardial nuclei. 48
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation. 48
Dynamics of protein binding to sites of nascent unscheduled DNA repair synthesis in non-proliferating cells 46
CREBBP and p300 lysine acetyl transferases in the DNA damage response 45
2-methoxyestradiol: New perspectives in colon carcinoma treatment. 44
Transcriptional stress induces chromatin relocation of the nucleotide excision repair factor XPG 44
CBP/p300-mediated acetylation of PCNA is required for its chromatin removal and degradation in nucleotide excision repair 43
Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*) 43
DNA damage accumulation and response in Down syndrome cell model systems 42
In situ analysis of DNA-protein complex formation upon radiation-induced DNA damage 41
An improved method for the detection of nucleotide excision repair factors at local UV DNA damage sites 41
Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro. 40
Investigating the role of p300 and CBP in Nucleotide Excision Repair: interaction with NER factors. 40
Immunocytometric determination of the alpha and beta isoforms of human DNA topoisomerase II: influence of different fixatives. 40
Biology of the cell cycle inhibitor p21(CDKN1A): molecular mechanisms and relevance in chemical toxicology. 40
In Vitro Neurotoxicity of Flumethrin Pyrethroid on SH-SY5Y Neuroblastoma Cells: Apoptosis Associated with Oxidative Stress 40
A damaged DNA binding protein 2 mutation disrupting interaction with proliferating-cell nuclear antigen affects DNA repair and confers proliferation advantage 40
Dynamics of p21CDKN1A recruitment to DNA repair sites depends on the interaction with PCNA 39
Pirazolcarbossiamidi e morte cellulare: una nuova arma per la chemioterapia. 39
Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. 39
Involvement of the cell cycle inhibitor p21CDKN1A in DNA repair. 38
Evidence of the role of PARP-1 - p21 complex in DNA repair 38
CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis 38
A functional in vitro cell-free system for studying DNA repair in isolated nuclei 38
Comparative studies on the effects of Doxorubicin and differentiation inducing agents on B16 melanoma cells 37
PCNA, PARP-1 and p21: a dynamic exchange of partners. 37
Modulation of p21CDKN1A protein levels by anticancer agents: a double-edged sword to fight genome instability. 37
Exploring new potential role of DDB2 by host cell reactivation assay in human tumorigenic cells 36
Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. 36
Differential involvement of DNases in HeLa cell apoptosis induced by etoposide and long term-culture. 36
p21 regulates the affinity of PARP-1 for damaged DNA 36
The cyclin-dependent inhibitor p21CDKN1A as a target of anti-cancer drugs. 35
PAR-mediated death response to oxidative stress in human cybrid models of Parkinson disease 35
Rubinstein-Taybi syndrome lymphoblastoid cells show oncreased sensitivity to oxidative DNA damage 35
Cytoplasmatic hybrids (PD cybrids) as a model system to investigate genome stability in Parkinson's disease 35
p21CDKN1A regulates the binding of poly (ADP-Ribose) polymerase-1 to DNA repair intermediates 35
Small ribosomal subunits associate with nuclear myosin and actin in transit to the nuclear pores. 35
DNA stainability with base-specific fluorochromes: dependence on the DNA topology in situ. 35
p300/CBP acetyl transferases interact with and acetylate the nucleotide excision repair factor XPG. 35
Nuclear binding of cell cycle-related proteins: cyclin A versus proliferating cell nuclear antigen (PCNA). 34
Role of the protein p21CDKN1A (Waf1/Cip1) in the DNA replication and repair pathways. 34
p21(CDKN1A) participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1 34
The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol. 34
A functional in vitro cell-free system for studying DNA repair in isolated nuclei 34
Degradation of p21(CDKN1A) after DNA damage is independent of type of lesion, and is not required for DNA repair. 34
Increase in p21CDKN1A protein levels by protesome inhibitors does not affect the apoptotic response after DNA damage. 34
Early recruitment of a pool of p21CDKN1A protein to nucleotide excision repair sites in human cells 33
Regulation of PARP-1 activity during Base Excision Repair: the role of p21CDKN1A 33
A basic role for p21CDKN1A in the DNA damage response by regulation of PCNA interaction with proteins involved in chromatin modification 33
DDB2 mutant protein unable to interact with PCNA promotes cell cycle progression of human transformed embryonic kidney cells 33
ENDOGENOUS DNA DAMAGE AND DNA REPAIR DEFICIENCY IN DOWN SYNDROME FIBROBLASTS 32
The acetyltranferases p300/CBP interact with, and acetylate XPG protein in nucleotide excision repair. 32
Delayed entry to quiescence by p21CDKN1A-null human fibroblasts: a possible involvement in the disassembly of pre-replication complex 31
Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. 31
Etoposide induces the dispersal of DNA ligase I from replication factories. 31
Cellular response to etoposide in H2AX deficient immortalized mouse embryonic fibroblasts. 31
An active mechanism flanks and modulates the export of the small ribosomal subunits. 31
p21 modulates PARP-1 recruitment to DNA repair sites. XIX Convegno Nazionale "I processi di ADP-ribosilazione" 31
Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells. 30
p21waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites. 30
Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes. 30
The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activity. 30
A variant of the Nijmegen breakage syndrome with unusual cytogenetic features and intermediate cellular radiosensitivity. 29
Flow cytometric analysis of DNA sensitivity to nuclease S1 in UVC-irradiated human fibroblasts. 29
Marcatori di proliferazione nucleare 29
Flow cytometric evaluation of DNA digestion with S1 nuclease. 29
Analysis of proliferating cell nuclear antigen (PCNA) associated with DNA excision repair sites in mammalian cells. 28
Cell cycle distribution of propteins involved in pre-replication versus dna replication as analysed by flow cytometry 28
p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition. 28
DNA sensitivity to S1 nuclease detected by base-specific fluorochromes. 28
Nuclear localisation of p21CDKN1A does not affect PCNA-dependent nucleotide excision repair in human cells 27
Identification of a new tubulin inhibitor that kills cancer cells 27
Effect of a new arylthioindole on HeLa cell metabolism. 27
Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts. 27
Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. 26
Analysis of p21CDKN1A recruitment to DNA excision repair foci in the UV-induced DNA damage response. 26
Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. 26
Activation of poly(ADP-ribose)polymerase in apoptotic human cells. 26
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions. 25
Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene. 25
Anthocyanins protect against oxidative damage in cell cultures 25
Expression of P21CDKN1A does not affect PCNA-dependent nucleotide excision repair in human cells 25
Dynamics of fluorescent protein-tagged p21CDKN1A and PCNA recruitment to dna repair sites 25
Parameters influencing the flow cytometric analysis of DNA sensitivity to nuclease S1. 25
Cyclins: relevance of subcellular localization in cell cycle control. 25
Effect of the topoisomerase II inhibitor Etoposide on H2AX deficient immortalized mouse embryonic fibroblasts. 25
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin. 24
Influence of Daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein 24
Nuclease-induced DNA structural changes assessed by flow cytometry with the intercalating dye propidium iodide. 24
Involvement of proliferating cell nuclear antigen in DNA repair after damage induced by genotoxic agents in human fibroblasts. 24
Totale 3.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.320
article - articoli 10.525
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 861
Totale 27.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 0 2 0 1 3
2024/20252.251 3 13 158 95 708 185 32 35 18 20 510 474
2025/20262.717 93 190 291 458 566 127 482 188 153 99 70 0
Totale 4.974